BOSTON, March 22, 2017 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a Boston-based securities litigation firm representing investors
nationwide, reminds investors of PixarBio Corporation (“PixarBio” or the “Company”) (OTCMKTS:PXRB) of the March 27, 2017 lead
plaintiff deadline.
If you purchased PixarBio securities in either the Company’s private placement, or on the open market
between October 31, 2016 and January 20, 2017, you are encouraged to contact attorney Bradley Vettraino at (617) 398-5600, by email
at bradley@blockesq.com, or by visiting www.blockesq.com/pixarbio.
On January 3, 2017, PixarBio's CEO announced a purported attempt by the Company to acquire InVivo Therapeutics
Holdings Corp. ("InVivo") in a $100 million takeover bid. InVivo refuted PixarBio’s purported offer as "not credible." On January
23, 2017, the SEC announced that it had halted trading in the securities of PixarBio, citing concerns about possible "manipulative
or deceptive activities" in the market for the Company's stock.
PixarBio’s stock plunged more than 35% during the month of January, causing tens of millions in losses to
investors.
The lawsuit subsequently filed by Block & Leviton against PixarBio and its CEO, in the United States District Court
for Massachusetts alleges that Defendants failed to disclose and/or made false and/or misleading statements regarding: (1) the
company’s business combinations and current shareholders; (2) the identity and qualifications of key shareholders and employees;
(3) the company’s current and prospective development efforts, and (4) that, as a result, the Company’s business, operations, and
prospects, were false and misleading.
As a member of the class, you may seek to file a motion to serve as a lead plaintiff or take no action and remain
an absent class member. Confidentiality to whistleblowers or others with information relevant to the lawsuit is assured.
Block & Leviton LLP is a Boston-based law firm representing investors nationwide. The firm's lawyers have
collectively been prosecuting securities cases on behalf of individual and institutional investors for over 50 years, and have
recovered billions of dollars on their behalf. Block & Leviton's investigations into corporate wrongdoing were recently covered by
the New York Times.
This notice may constitute attorney advertising.
CONTACT: Block & Leviton LLP Bradley J. Vettraino 155 Federal Street, Suite 400 Boston, MA 02110 (617) 398-5600 bradley@blockesq.com
